Medical/Pharmaceuticals
Geltor Raises $91.3M as Pandemic Exposes Need for Sustainable Protein Supply Chain
Biodesign Leader to Expand Its Sustainable Ingredients-as-a-Service™ Platform Globally SAN LEANDRO, California, July 28, 2020 /PRNewswire/ -- Geltor today announced the closing of a$91.3M Series B financing that will fuel the global expansion of its Ingredients-as-a-Service™ platform. The fundin...
2020-07-28 02:08
2433
Global Healthcare Interoperability Market to Witness Nearly Two-fold Growth by 2024
SANTA CLARA, California, July 27, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Global Healthcare Interoperability Market, Forecast to 2024, contends that interoperability has become a critical consideration for all health IT (HIT) applications. Countries where HIT interoperability stan...
2020-07-27 22:01
2757
K-BioMed Pioneer: VUNO Med®-Fundus AI™ Becomes Korea's First-ever Innovative Medical Device
SEOUL, South Korea, July 27, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer and a member company of theBorn2Global Centre, announced that VUNO Med®-Fundus AI™, its AI-based screening solution for the fundus, gained the honor of being the first-ever Innovative ...
2020-07-27 22:00
2535
From The Alzheimer's Association International Conference 2020: Flu, Pneumonia Vaccinations Tied To Lower Risk Of Alzheimer's Dementia
CHICAGO, July 27, 2020 /PRNewswire/ -- Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at theAlzheimer's Association International Conference ® (AAIC®) 2020. Three research studies reported at AAIC 2020 su...
2020-07-27 13:01
4129
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals (Hangzhou, China) is pleased to announce exclusive licensing agreements with Kobe University (Kobe, Japan) and with RIKEN Research Institute (Saitama, Japan) to develop RAS inhibitors with a novel MOA. The agreement withKobe Univ...
2020-07-27 07:00
4088
VISTA Eye Specialists Collaborates with Alcon Malaysia and Tigas Pharmacy to Raise Awareness on Dry Eyes
KUALA LUMPUR, Malaysia, July 25, 2020 /PRNewswire/ -- VISTA Eye Specialist (VISTA), in collaboration with Alcon Malaysia and Tigas Pharmacy, will be sharing via a Facebook Live Webinar on28 July 2020, 8.30pm titled 'Bye Bye Dry Eyes' discussing about the complete management of Dry Eyes Disease (D...
2020-07-25 08:00
5800
FUJIFILM Sonosite Launches New Point-Of-Care Ultrasound System With Adaptable Form Factor, Embedded Workflow, And The Most Advanced Image Clarity Sonosite Has Ever Offered
BROOKVALE, New South Wales, July 24, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the largerFujifilm Healthcare portfolio, has announced the launch of the new Sonosite PX ultrasound system. Sonosite PX...
2020-07-24 07:00
2786
Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant
- Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development - Elacestrant further strengthens Menarini's global oncology portfolio, recently bolstered by the acquisition of Stemline Therapeutics in the U.S. - Radius...
2020-07-24 06:16
4620
APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer
APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology. DELHI, India, July 23, 2020 /...
2020-07-23 22:00
2888
Clarity Pharmaceuticals opens SARTATE neuroblastoma clinical trial
SYDNEY, July 23, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has opened its trial of67Cu-SARTATE™ for paediatric patients with neuroblastoma at Memorial Sloan Kettering Cancer Center (MSK) ...
2020-07-23 21:13
2018
N.B. Quadriga's Transformative Treatment for Brain Cancers Dosed in First Human Subject
SHANGHAI and NANTONG, China, July 23, 2020 /PRNewswire/ -- N.B. Quadriga (NBQ), a clinical stage biopharmaceutical company developing transformative medicines for brain cancers, today announced that the first patient has been dosed in a Phase 1 study of NBQ72S, also known as QBS10072S, in pati...
2020-07-23 19:00
3870
Zhongchao Inc. Joined Hands with Professional Non-Profit Organizations and 9 Leading Pharma Companies to Carry Out Multi-Year Online Education Project on Diagnosis and Treatment of Primary Liver Cancer
SHANGHAI, July 23, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it joined hands with China Health P...
2020-07-23 18:30
4144
InnoTier launched new sustainable and innovative products in Hong Kong amid COVID-19 pandemic
HONG KONG, July 23, 2020 /PRNewswire/ -- InnoTier, the lifestyle consumer brand under Julius Group, has announced to launch four innovative products inHong Kong with the aim of enabling people to lead more sustainable lives in a rapidly changing world. Against the backdrop of the current global p...
2020-07-23 14:06
7835
Bupa Global Research finds Hong Kong and Mainland China senior executives increasingly concerned about health issues
* A majority of senior executives in Hong Kong (87.6%) and Mainland China (70.5%) have experienced physical and mental health pressure amid the outbreak of COVID-19, but less than 9% seeking professional support * Only 32% and 25.2% of Hong Kong senior executives stated financial stability, and...
2020-07-22 17:38
4189
Ascentage Pharma Announces First Patient Dosed in the Phase Ib Study of MDM2-p53 Inhibitor APG-115 as Single Agent and in Combinations for the Treatment of Hematologic Malignancies in China
SUZHOU, China and ROCKVILLE, Md., July 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase Ib study of t...
2020-07-22 17:31
2250
Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test
SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...
2020-07-21 23:00
1968
Surgere: AutoSphere Gains Altitude - Faster Than Ever
CLEVELAND and TOKYO and ANTWERP, Belgium and AGUASCALIENTES, Mexico, July 21, 2020 /PRNewswire/ -- The Surgere Automotive Supply Chain Community has reached record numbers. The community's amazing growth includes 136 sites in theNorth America and 64 sites in Asia Pacific since January 2020. AutoS...
2020-07-21 22:07
3557
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum
SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...
2020-07-21 22:04
2663
Ortho Care(TM) Again Ranks No. 1 for Service in Diagnostics Industry
RARITAN, N.J., July 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics in...
2020-07-21 22:00
2813
Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets
SYDNEY and LOS ANGELES, July 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop n...
2020-07-21 21:13
2055
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8546
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7700